Clinical Trials in Poland / NCT04879069
Recruiting Observational

Polish Multicenter PERTs PE Outcomes Registry

NCT04879069 · tracked via the Priya Life Science Poland tracker
Phase
Observational
Started
2018-06-01
Last updated
2021-05-10

Condition(s) studied

Pulmonary Embolism With Acute Cor Pulmonale

Study summary

Pulmonary embolism (PE) is the third leading cause of cardiovascular mortality. The Pulmonary Embolism Response Team (PERT) concept offers a rapid and multidisciplinary approach focused on improving outcomes for patients with PE. All institutionalized PERTs in Poland have been invited to join the study. The goal of this registry is to describe current practice and outcomes in patients with acute PE treated by Polish PERTs.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. PE confirmed by computed tomography pulmonary angiography. 2. PE symptoms duration ≤ 14 days. 3. High-risk PE with hemodynamic instability (one of): * cardiac arrest * obstructive shock * persistent hypotension. 4. Intermediate-high risk PE patients with right ventricle dysfunction confirmed by imaging studies and elevated troponin level. Exclusion Criteria: 1\. Refusal to sign the informed consent form.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Poznan University of Medical Sciences Poznan GreaterPoland Recruiting

More Poznan University of Medical Sciences trials in Poland

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04879069 on ClinicalTrials.gov ↗ ← All trials in Poland